Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity? Murdoch IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, et al. AIDS 2022;36:322-323.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Murdoch IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, et al. Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity? AIDS 2022;36:322-323.
PMID: 34934024